Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION In biotechnology, developing a new cutting-edge treatment that will help millions of Americans, and doing it faster than anyone else, is what you’re supposed to do. But being a thought leader in the field is who you…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A life sciences team was completing specialized research on new technology in the organ transplant space on behalf of a medical device company. Their research included different perfusion methods (e.g., hypothermic vs. normothermic machine perfusion) and they…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kai Wulff, CEO of Plexus Group Ltd While all business schools are still busy teaching Management, we have stopped asking what purpose Management serves. We’ve also stopped focusing on how we can achieve the same, or higher, level of…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Ken Wahl, VP Business Development, Data Insights, Guidepoint Nevro Corp. (NYSE: NVRO) is a key player in the spinal cord stimulation (SCS) market. Since FDA approval of the Senza system in 2015, Nevro has taken ~15% market share from…

Read More

Update on Business Immunity to COVID-19 Lawsuits

By Michael P. Fischetti, Executive Director, National Contract Management Association A colleague recently mentioned a small, but very significant, refrain learned early in what became a long, distinguished career; “Instead of ‘No, because,’ say ‘Yes, if’.” Acquisition challenges and hurdles,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Mike McCully, President of The McCully Group In less than a month following Q1 2018, the dairy markets have awakened. While some expect further gains due to tighter supply-demand conditions, others point to adequate stocks for most products. International…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Mike McCully, President of The McCully Group In less than a month following Q1 2018, the dairy markets have awakened. While some expect further gains due to tighter supply-demand conditions, others point to adequate stocks for most products. International…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Abiomed, Inc. (NYSE: ABMD) is a leader in the percutaneous heart pump device market, having launched its first Impella device in 2008 and have since released four iterations with varying flow rates. From May…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a leading consulting firm wanted to better understand how anti-cancer pharmaceuticals are evaluated for inclusion on payer formularies. They were conducting strategy research on behalf of a pharmaceutical company. They needed a large…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A due diligence team at a leading consulting firm needed to quickly get up to speed on data center storage solutions. To better understand the major players and potential market size for these solutions, they were looking…

Read More